Anzeige
Mehr »
Mittwoch, 02.07.2025 - Börsentäglich über 12.000 News
Nächster Kursturbo?: 226 % Plus seit Januar - wie weit kann diese Aktie noch steigen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
411 Leser
Artikel bewerten:
(1)

Physician Growth Partners Advises Corrective Eye Center in Its Acquisition by EyeCare Partners

CHICAGO, IL / ACCESSWIRE / August 25, 2020 / Physician Growth Partners ("PGP") is pleased to announce the acquisition of Corrective Eye Center ("Corrective Eye"), a leading ophthalmology group based in the Northeast Ohio market, by EyeCare Partners. Corrective Eye is led by Dr. Samuel Salamon and Dr. Greg Louis, along with two associate physicians across three locations and a surgery center. This strategic acquisition creates an entry point for EyeCare Partners to begin providing ophthalmic care across the greater Cleveland market.

Physician Growth Partners served as the exclusive transaction advisor to Corrective Eye in its evaluation, negotiation, and execution of this transaction. PGP focuses exclusively on advising independent practices in transactions with private equity. PGP's approach centers around understanding goals and succession plans, and tailoring a process that ensures these goals are met in an optimal manner.

To accomplish this, PGP's main focus is on shareholder education related to strategic options. This allows clients to make an informed decision on the best route forward. From there, PGP works to truly gain a fundamental understanding of practice goals & objectives, its unique value proposition, and how to best marry the two in a way that allows PGP, as the transaction advisor, to run a process aimed at achieving the desired optimal outcome.

Dr. Samuel Salamon of Corrective Eye Center noted, "The PGP team, especially Michael Kroin and Thomas Mumford, succeeded in advising our practice through the transaction process, and we are most pleased with the outcome. We know this partnership would not have been consummated without their demonstrable expertise, experience, professionalism, and attention to detail at every step of the way."

Kathleen Zampounis, Practice Administrator at Corrective Eye Center added, "My experience with PGP was smooth, and the PGP Team was motivated, thorough, and very detailed throughout the process. The dedication and long hours spent with Michael Kroin, Thomas Mumford, and Jay Farkas, was amazing. Never having gone through a process like this, we could have never managed without PGP's broad knowledge and assistance. I look forward to the partnership with EyeCare Partners."

"We are extremely satisfied with Corrective Eye's transaction process. The goals of the practice were achieved, and that is always PGP's number one priority. We knew Corrective Eye had a strong desire to join a platform that would alleviate the practice management burden while simultaneously empowering the practice to continue growing. The well-established EyeCare Partners platform clearly had the managerial resources to relieve the burden on day one. The fit was right on both sides, and with the addition of Corrective Eye to Eyecare Partners platform, we believe the group is well aligned for continued growth and expanded delivery of exceptional clinical care," noted Michael Kroin, Managing Partner at Physician Growth Partners.

About Physician Growth Partners

Physician Growth Partners is a boutique healthcare service platform dedicated to advising physician practices in transactions with private equity. PGP creates value by providing operational support, strategic positioning, and transaction advisory, ultimately realizing an optimal outcome for their clients.

About EyeCare Partners

Based in St. Louis, Missouri, EyeCare Partners currently offers comprehensive medical eye care services throughout Alabama, Arizona, Florida, Georgia, Illinois, Indiana, Kansas, Kentucky, Michigan, Minnesota, Missouri, New Jersey, North Carolina, Ohio, and Pennsylvania. The doctors of ECP serve the vision care needs of hundreds of thousands of patients annually.

For more information about Physician Growth Partners, contact the company here:

Physician Growth Partners
Michael Kroin
630 - 299 - 6260
Mkroin@physiciangrowthpartners.com
222 W Ontario St Ste. 315, Chicago, IL 60654

SOURCE: Physician Growth Partners



View source version on accesswire.com:
https://www.accesswire.com/603387/Physician-Growth-Partners-Advises-Corrective-Eye-Center-in-Its-Acquisition-by-EyeCare-Partners

© 2020 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.